Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Choline tetrathiomolybdate

EU orphan designation number: EU/3/12/1089   
Active ingredient: Choline tetrathiomolybdate
Indication: Treatment of Wilson’s disease
Sponsor: Wilson Therapeutics AB
Västra Trädgårdsgatan 15, 111 53 Stockholm, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/01/2013 Orphan Designation EMA/OD/142/12 (2013)478 of 24/01/2013
01/08/2014 Transfer of orphan designation EMA/OD/142/12/T/01 (2014)5575 of 30/07/2014